Statistics Experts Review Data Sets In Pharmaceutical Drug Report

ByVictoria Negron

|

Updated onMay 1, 2018

Statistics Experts Review Data Sets In Pharmaceutical Drug Report

This case involves several autistic male children who developed gynecomastia after taking the drug risperidone. It was alleged that the pharmaceutical company that marketed this drug hid evidence that would have alerted clinicians and regulatory authorities to the connection between risperidone, increased prolactin, and gynecomastia. An early study on the drug’s side effects allegedly included multiple data sets that reported a direct link between increased prolactin levels and side effects like gynecomastia. These findings were allegedly redacted from the published manuscript and the published version concluded that the drug produced no prolactin-associated side effects. An expert in statistics was sought to review the original drug report and determine whether this paper should be retracted and what data any retraction would cover.

Question(s) For Expert Witness

1. Please describe your experience conducting statistical analysis for drug trials or biomedical research.

2. Have you lectured or been published in this field?

Expert Witness Response E-035914

inline imageI am a biostatistician with 30+ years of experience designing, reviewing, and analyzing over 420 clinical trials. I am well-versed in issues associated with biostatistics, data management, statistical programming, and regulatory affairs. My professional experience spans various therapeutics areas including psychiatry, neurology, oncology, endocrinology, infectious disease, cardiology, rheumatology, urology, and anesthesia. As a former vice president of biometrics at large pharmaceutical companies and contract research organizations, I have managed biostatisticians and statistical programmers in the pre-clinical, non-clinical, and clinical areas. I also led initiatives of implementing adaptive designs of clinical trials to improve clinical drug development.

About the author

Victoria Negron

Victoria Negron

Victoria Negron has extensive experience in journalism and thought leadership in the legal space, with a background crafting content, whitepapers, webinars, and current event articles pertaining to the role of expert witnesses in complex litigation matters. She is a skilled professional specializing in B2B product marketing and content marketing. Currently, she serves as an Enterprise Product Marketing Manager at Postman, and previously held the position of Technical Product Marketing Manager at Palantir Technologies, where she developed her skills in launch strategies, go-to-market strategy, and competitive analysis.

Her expertise in content marketing was further refined during her tenure at the Expert Institute, where she progressed from a Marketing Writer to Senior Content Marketing Manager, and eventually to Associate Director of Content & Product Marketing. In these roles, she honed her abilities in digital marketing, SEO, content strategy, and thought leadership.

Educationally, Victoria holds a Master of Business Administration from the University of Florida - Warrington College of Business and a Bachelor of Arts in Literature, Art, and Hispanic Studies from Hamilton College. Her diverse educational background and professional experience have equipped her with a robust skill set in product marketing, content development, and strategic marketing initiatives.

Find an expert witness near you

What State is your case in?

What party are you representing?